FDA Approves, Leqembi, New Treatment for Early Alzheimer’s The drug, Leqembi, may modestly slow cognitive decline in early [...] By digitalstudios|2023-01-06T22:58:48+00:00January 6, 2023|3rd Party Pharmaceutical Industry News|Comments Off on FDA Approves, Leqembi, New Treatment for Early Alzheimer’s Read More
